NPH: Clinical Trials

10 trials of NPH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 recruiting, 1 active not recruiting, 1 terminated. 4 Not applicable, 2 Phase 2, 2 Phase 4, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Recruiting 2, Terminated 1, Withdrawn 1
Phase 22Active not recruiting 1, Completed 1
Phase 42Completed 2
Early Phase 11Completed 1
Phase 31Completed 1

Follow NPH: new trials by email Literature Review of NPH trials Research Report on NPH

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
Insulin - Gestational Diabetes, Pregnancy Related
Not applicableRecruitingThomas Jefferson University4302024-09-012024-11-22
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes
Insulin - Gestational Diabetes, Pregnancy Related
Not applicableRecruitingThomas Jefferson University4302024-09-012024-11-21
Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
Sliding Scale Insulin, Up-Titration of Home Insulin, Continuous Insulin Infusion - Diabetes Mellitus, Type 2, Preterm Birth
Phase 2Active not recruitingUniversity of Alabama at Birmingham1202022-02-102026-07-14
Insulin Schemes for Type 2 Diabetes Control
NPH insulin, Glargine and Lispro insulin - Type 2 Diabetes Mellitus
Phase 4CompletedUniversidad de Guanajuato752017-11-022021-12-06
The Inova Type 2 Diabetes Mellitus Study
Glargine, NPH - Diabetes, Type 2
Not applicableWithdrawnInova Health Care Services2015-04-012016-08-05
Inpatient Diabetes on Corticosteroids
NPH, Correction Factor - Diabetes Mellitus
Phase 4CompletedHennepin Healthcare Research Institute852014-07-012019-10-01
Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients
Insulin protocol - Lymphoma, Diabetes Mellitus, Type 2
Early Phase 1CompletedWashington University School of Medicine152013-09-012018-05-07
Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
NPH, Insulin LISPRO, Insulin glulisine - Diabetes During Pregnancy
Phase 2CompletedSansum Diabetes Research Institute172013-04-012018-04-18
Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis
NPH, Detemir, Glargine - Diabetes Mellitus, Type 1
Phase 3CompletedUniversity of Aarhus192012-02-012012-12-04
Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
Insulin detemir, Glargine, NPH - Type 1 Diabetes
Not applicableTerminatedUniversity of Texas Southwestern Medical Center332006-09-012019-10-11

Conditions studied

Diabetes Mellitus, Type 2 (4)  ·  Diabetes, Gestational (4)  ·  Insulin Resistance (4)  ·  Diabetes Mellitus (2)  ·  Diabetes Mellitus, Type 1 (2)  ·  Hyperglycemia (1)  ·  Hypoglycemia (1)  ·  Lymphoma (1)  ·  Premature Birth (1)

Sponsors

Thomas Jefferson University (2)  ·  Hennepin Healthcare Research Institute (1)  ·  Inova Health Care Services (1)  ·  Sansum Diabetes Research Institute (1)  ·  Universidad de Guanajuato (1)  ·  University of Aarhus (1)  ·  University of Alabama at Birmingham (1)  ·  University of Texas Southwestern Medical Center (1)  ·  Washington University School of Medicine (1)

Countries

United States (8)  ·  Denmark (1)  ·  Mexico (1)

Top investigators

Anna Roshal, MD (1)  ·  Ashley N Battarbee, MD (1)  ·  Garry Tobin, MD (1)  ·  Jens Sandahl Christiansen, M.D. (1)  ·  Jose A Alvarez, PhD (1)  ·  Kristin Castorino, DO (1)  ·  Leonie Mattison, PhD (1)  ·  Lisa Fish, MD (1)  ·  Soumya Adhikari, MD (1)  ·  Stephen C Clement, MD (1)

Results publications

PMID 15951574, PMID 19797280, PMID 21078733, PMID 21288502, PMID 23601190, PMID 23712381, PMID 27054932, PMID 27182178, PMID 29125636, PMID 29370047, PMID 29961246, PMID 31424780, PMID 33308193, PMID 34000260, PMID 35877134, PMID 8598962

NIH funding

K23HD103875 (1)